日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/07/27 | 8,380 | 8,420 | 8,250 | 8,300 | +110 | +1.3% | 128,000 |
| 2022/07/26 | 8,240 | 8,250 | 8,170 | 8,190 | -70 | -0.8% | 80,500 |
| 2022/07/25 | 8,250 | 8,320 | 8,250 | 8,260 | -40 | -0.5% | 70,000 |
| 2022/07/22 | 8,320 | 8,370 | 8,240 | 8,300 | -60 | -0.7% | 115,600 |
| 2022/07/21 | 8,300 | 8,360 | 8,220 | 8,360 | -60 | -0.7% | 190,500 |
| 2022/07/20 | 8,320 | 8,440 | 8,290 | 8,420 | +190 | +2.3% | 188,900 |
| 2022/07/19 | 8,330 | 8,330 | 8,120 | 8,230 | -110 | -1.3% | 145,200 |
| 2022/07/15 | 8,380 | 8,450 | 8,250 | 8,340 | +110 | +1.3% | 126,600 |
| 2022/07/14 | 8,260 | 8,310 | 8,190 | 8,230 | -30 | -0.4% | 123,400 |
| 2022/07/13 | 8,370 | 8,390 | 8,130 | 8,260 | -70 | -0.8% | 139,300 |
| 2022/07/12 | 8,420 | 8,460 | 8,290 | 8,330 | -130 | -1.5% | 148,300 |
| 2022/07/11 | 8,440 | 8,550 | 8,420 | 8,460 | +150 | +1.8% | 181,900 |
| 2022/07/08 | 8,340 | 8,390 | 8,220 | 8,310 | -10 | -0.1% | 189,500 |
| 2022/07/07 | 8,220 | 8,380 | 8,180 | 8,320 | +160 | +2% | 261,600 |
| 2022/07/06 | 7,950 | 8,200 | 7,900 | 8,160 | +250 | +3.2% | 219,800 |
| 2022/07/05 | 7,830 | 7,950 | 7,770 | 7,910 | +100 | +1.3% | 191,100 |
| 2022/07/04 | 7,760 | 7,860 | 7,710 | 7,810 | +140 | +1.8% | 223,500 |
| 2022/07/01 | 7,800 | 7,850 | 7,660 | 7,670 | -580 | -7% | 456,800 |
| 2022/06/30 | 8,370 | 8,430 | 8,220 | 8,250 | +50 | +0.6% | 238,300 |
| 2022/06/29 | 8,060 | 8,250 | 8,030 | 8,200 | -10 | -0.1% | 446,600 |
| 2022/06/28 | 8,090 | 8,210 | 8,000 | 8,210 | +210 | +2.6% | 174,800 |
| 2022/06/27 | 7,940 | 8,060 | 7,850 | 8,000 | -20 | -0.2% | 204,000 |
| 2022/06/24 | 8,030 | 8,050 | 7,820 | 8,020 | +270 | +3.5% | 257,100 |
| 2022/06/23 | 7,690 | 7,860 | 7,690 | 7,750 | +80 | +1% | 149,100 |
| 2022/06/22 | 7,590 | 7,720 | 7,540 | 7,670 | +170 | +2.3% | 220,600 |
| 2022/06/21 | 7,500 | 7,580 | 7,430 | 7,500 | +50 | +0.7% | 171,700 |
| 2022/06/20 | 7,370 | 7,500 | 7,340 | 7,450 | +200 | +2.8% | 209,300 |
| 2022/06/17 | 7,030 | 7,290 | 7,030 | 7,250 | +240 | +3.4% | 355,700 |
| 2022/06/16 | 7,240 | 7,270 | 7,000 | 7,010 | -230 | -3.2% | 276,300 |
| 2022/06/15 | 7,340 | 7,340 | 7,200 | 7,240 | -250 | -3.3% | 214,000 |
| 2022/06/14 | 7,500 | 7,590 | 7,370 | 7,490 | -130 | -1.7% | 247,500 |
| 2022/06/13 | 7,560 | 7,700 | 7,540 | 7,620 | +20 | +0.3% | 223,500 |
| 2022/06/10 | 7,610 | 7,650 | 7,520 | 7,600 | -60 | -0.8% | 143,100 |
| 2022/06/09 | 7,610 | 7,800 | 7,580 | 7,660 | -50 | -0.6% | 188,100 |
| 2022/06/08 | 7,590 | 7,730 | 7,460 | 7,710 | +290 | +3.9% | 238,300 |
| 2022/06/07 | 7,480 | 7,540 | 7,390 | 7,420 | -80 | -1.1% | 208,500 |
| 2022/06/06 | 7,520 | 7,620 | 7,500 | 7,500 | -20 | -0.3% | 161,500 |
| 2022/06/03 | 7,650 | 7,680 | 7,470 | 7,520 | -80 | -1.1% | 257,300 |
| 2022/06/02 | 7,810 | 7,810 | 7,590 | 7,600 | -260 | -3.3% | 168,500 |
| 2022/06/01 | 7,960 | 8,010 | 7,860 | 7,860 | -110 | -1.4% | 159,600 |
| 2022/05/31 | 8,070 | 8,190 | 7,970 | 7,970 | -90 | -1.1% | 685,300 |
| 2022/05/30 | 7,920 | 8,070 | 7,920 | 8,060 | +230 | +2.9% | 531,000 |
| 2022/05/27 | 7,760 | 7,880 | 7,600 | 7,830 | +180 | +2.4% | 331,300 |
| 2022/05/26 | 7,830 | 7,950 | 7,650 | 7,650 | -180 | -2.3% | 159,800 |
| 2022/05/25 | 7,880 | 7,950 | 7,790 | 7,830 | -100 | -1.3% | 186,800 |
| 2022/05/24 | 7,940 | 7,980 | 7,870 | 7,930 | -100 | -1.2% | 131,100 |
| 2022/05/23 | 7,880 | 8,070 | 7,860 | 8,030 | +200 | +2.6% | 192,000 |
| 2022/05/20 | 7,760 | 7,870 | 7,710 | 7,830 | +200 | +2.6% | 243,100 |
| 2022/05/19 | 7,600 | 7,720 | 7,590 | 7,630 | -120 | -1.5% | 245,400 |
| 2022/05/18 | 7,540 | 7,790 | 7,520 | 7,750 | +280 | +3.7% | 324,000 |
701～
750
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 168,300円 | +5.0% | +1.5% | 0.00% | 14.40倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
